S
Stein Kvaløy
Researcher at University of Oslo
Publications - 78
Citations - 12869
Stein Kvaløy is an academic researcher from University of Oslo. The author has contributed to research in topics: Lymphoma & Diffuse large B-cell lymphoma. The author has an hindex of 24, co-authored 77 publications receiving 12063 citations. Previous affiliations of Stein Kvaløy include Oslo University Hospital.
Papers
More filters
Journal ArticleDOI
Cost of autologous peripheral blood stem cell transplantation: the Norwegian experience from a multicenter cost study
Vinod Mishra,S. Andresen,Lorentz Brinch,Stein Kvaløy,P. Ernst,M. K. Lønset,Jon Magnus Tangen,J. Wikelund,C. Flatum,E. Baggerød,B. Helle,Stein Vaaler,Terje P. Hagen +12 more
TL;DR: High-dose therapy with autologous blood progenitor cell support is now routinely used for patients with certain malignant lymphomas and multiple myeloma, indicating that the treatment of these patients was heavily subsidized by the basic hospital grants.
Journal ArticleDOI
Prognostic value of lymphoma-specific S-phase fraction compared with that of other cell proliferation markers.
TL;DR: Of the proliferation-associated parameters, only high S-phase fraction and high PCNA expression by immunoblotting were predictive of a poor prognosis, while conventional parameters, high-grade malignancy, high International Prognostic Index (IPI) score, bulky disease and presence of B symptoms predicted a patient for poor survival.
Journal ArticleDOI
Spontaneous (3H)-Thymidine Uptake in Histological Subgroups of Human B-Cell Lymphomas
TL;DR: Spontaneous (3H)-TdR incorporation was studied in cell suspensions from 64 patients with monoclonal B-cell neoplasias and data suggest that there exists correlation between prognosis as determined by histopathology and spontaneous uptake of ( 3H)- TdR.
Journal ArticleDOI
Utilization of Radiation Therapy in Norway After the Implementation of The National Cancer Plan—A National, Population-Based Study
Linn M. Åsli,Stein Kvaløy,Vidar Jetne,T.A. Myklebust,Sverre G. Levernes,Sverre G. Levernes,Kjell Magne Tveit,Tor O. Green,Tom Børge Johannesen +8 more
TL;DR: Utilization rates of RT in Norway increased after the NCP was implemented and RT capacity was increased, but they still seem to be lower than optimal levels.
Journal ArticleDOI
Late medical sequelae after therapy for supradiaphragmatic Hodgkin's disease.
A. F. Abrahamsen,Jon Håvard Loge,E. Hannisdal,O. Nome,May Brit Lund,Harald Holte,Stein Kvaløy +6 more
TL;DR: A total of 221 consecutive early stage Hodgkin's disease patients given mantle field irradiation only or in combination with chemotherapy in 1971-1991 responded to a mailed self-report questionnaire covering items on late medical symptoms in 1994, finding that 110 patients had thyroid hypofunction at follow-up in 1994.